24/7 Patient Assistance: 760-405-8205

Mihaela Cristea, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Mihaela Cristea is a specialist in medical oncology in Duarte, California and she is working in collaboration with the City of Hope. She graduated from University of Medicine and Pharmacy Pope Gregory where she got her medical degree. She did her residency program in internal medicine at Monmouth Medical Center and a fellowship in medical oncology at University of Florida College of Medicine at Jacksonville. The doctor is board certified in medical oncology and she has been practicing for more than 20 years.


  • Education & Training

    dept_icon

    University of Medicine and Pharmacy Pope Gregory

    Medical School

    dept_icon

    Monmouth Medical Center

    Residency

    dept_icon

    University of Florida College of Medicine at Jacksonville

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    City of Hope Duarte - Comprehensive Cancer Center

    Languages: English/Spanish

    (800) 826-4673

    1500 East Duarte Road

    Duarte, California 91010

    Read More
  • Publications & Memberships

    Dr. Mihaela Cristea has contributed to 3 publications.

    Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical Procedures.

    Raz, D. J.,Sun, V.,Kim, J. Y.,Williams, A. C.,Koczywas, M.,Cristea, M.,Reckamp, K.,Hayter, J.,Tiep, B.,Ferrell, B.; Ann. Thorac. Surg.. 2015 Oct 08.

    See more >>

    Interdisciplinary Palliative Care for Patients With Lung Cancer.

    Ferrell, B.,Sun, V.,Hurria, A.,Cristea, M.,Raz, D. J.,Kim, J. Y.,Reckamp, K.,Williams, A. C.,Borneman, T.,Uman, G.,Koczywas, M.; J Pain Symptom Manage. 2015 Aug 25.

    See more >>

    Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors.

    Koczywas, M.,Frankel, P. H.,Synold, T. W.,Lenz, H. J.,Mortimer, J. E.,El-Khoueiry, A. B.,Gandara, D. R.,Cristea, M. C.,Chung, V. M.,Lim, D.,Reckamp, K. L.,Lau, D. H.,D...; Br. J. Cancer. 2014 Oct 29.

    See more >>